List of Tables
Table 1. Global Acquired Immunodeficiency Syndrome Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Table 3. Key Players of Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Table 4. Global Acquired Immunodeficiency Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Acquired Immunodeficiency Syndrome Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Acquired Immunodeficiency Syndrome Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Acquired Immunodeficiency Syndrome Market Share by Region (2020-2025)
Table 8. Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Acquired Immunodeficiency Syndrome Market Share by Region (2026-2031)
Table 10. Acquired Immunodeficiency Syndrome Market Trends
Table 11. Acquired Immunodeficiency Syndrome Market Drivers
Table 12. Acquired Immunodeficiency Syndrome Market Challenges
Table 13. Acquired Immunodeficiency Syndrome Market Restraints
Table 14. Global Acquired Immunodeficiency Syndrome Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Acquired Immunodeficiency Syndrome Market Share by Players (2020-2025)
Table 16. Global Top Acquired Immunodeficiency Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Immunodeficiency Syndrome as of 2024)
Table 17. Ranking of Global Top Acquired Immunodeficiency Syndrome Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Acquired Immunodeficiency Syndrome Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Acquired Immunodeficiency Syndrome, Headquarters and Area Served
Table 20. Global Key Players of Acquired Immunodeficiency Syndrome, Product and Application
Table 21. Global Key Players of Acquired Immunodeficiency Syndrome, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acquired Immunodeficiency Syndrome Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Type (2020-2025)
Table 25. Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Type (2026-2031)
Table 27. Global Acquired Immunodeficiency Syndrome Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Application (2020-2025)
Table 29. Global Acquired Immunodeficiency Syndrome Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Application (2026-2031)
Table 31. North America Acquired Immunodeficiency Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Acquired Immunodeficiency Syndrome Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Acquired Immunodeficiency Syndrome Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Acquired Immunodeficiency Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Acquired Immunodeficiency Syndrome Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Acquired Immunodeficiency Syndrome Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Acquired Immunodeficiency Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Acquired Immunodeficiency Syndrome Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Acquired Immunodeficiency Syndrome Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2026-2031) & (US$ Million)
Table 46. Takeda Company Details
Table 47. Takeda Business Overview
Table 48. Takeda Acquired Immunodeficiency Syndrome Product
Table 49. Takeda Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025) & (US$ Million)
Table 50. Takeda Recent Development
Table 51. AstraZeneca Eli Lilly and Company Company Details
Table 52. AstraZeneca Eli Lilly and Company Business Overview
Table 53. AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Product
Table 54. AstraZeneca Eli Lilly and Company Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025) & (US$ Million)
Table 55. AstraZeneca Eli Lilly and Company Recent Development
Table 56. Merck KGaA Company Details
Table 57. Merck KGaA Business Overview
Table 58. Merck KGaA Acquired Immunodeficiency Syndrome Product
Table 59. Merck KGaA Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025) & (US$ Million)
Table 60. Merck KGaA Recent Development
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Acquired Immunodeficiency Syndrome Product
Table 64. Sanofi Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Acquired Immunodeficiency Syndrome Product
Table 69. Pfizer Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Amgen Company Details
Table 72. Amgen Business Overview
Table 73. Amgen Acquired Immunodeficiency Syndrome Product
Table 74. Amgen Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Biogen Company Details
Table 77. Biogen Business Overview
Table 78. Biogen Acquired Immunodeficiency Syndrome Product
Table 79. Biogen Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025) & (US$ Million)
Table 80. Biogen Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Acquired Immunodeficiency Syndrome Product
Table 84. Novartis Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Actelion Company Details
Table 87. Actelion Business Overview
Table 88. Actelion Acquired Immunodeficiency Syndrome Product
Table 89. Actelion Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025) & (US$ Million)
Table 90. Actelion Recent Development
Table 91. Daiichi Sankyo Company Company Details
Table 92. Daiichi Sankyo Company Business Overview
Table 93. Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Product
Table 94. Daiichi Sankyo Company Revenue in Acquired Immunodeficiency Syndrome Business (2020-2025) & (US$ Million)
Table 95. Daiichi Sankyo Company Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Acquired Immunodeficiency Syndrome Picture
Figure 2. Global Acquired Immunodeficiency Syndrome Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Acquired Immunodeficiency Syndrome Market Share by Type: 2024 VS 2031
Figure 4. Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Features
Figure 5. Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features
Figure 6. Global Acquired Immunodeficiency Syndrome Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Acquired Immunodeficiency Syndrome Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Others Case Studies
Figure 11. Acquired Immunodeficiency Syndrome Report Years Considered
Figure 12. Global Acquired Immunodeficiency Syndrome Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Acquired Immunodeficiency Syndrome Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Acquired Immunodeficiency Syndrome Market Share by Region: 2024 VS 2031
Figure 15. Global Acquired Immunodeficiency Syndrome Market Share by Players in 2024
Figure 16. Global Top Acquired Immunodeficiency Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Immunodeficiency Syndrome as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Acquired Immunodeficiency Syndrome Revenue in 2024
Figure 18. North America Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Acquired Immunodeficiency Syndrome Market Share by Country (2020-2031)
Figure 20. United States Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Acquired Immunodeficiency Syndrome Market Share by Country (2020-2031)
Figure 24. Germany Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Acquired Immunodeficiency Syndrome Market Share by Region (2020-2031)
Figure 32. China Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Acquired Immunodeficiency Syndrome Market Share by Country (2020-2031)
Figure 40. Mexico Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Acquired Immunodeficiency Syndrome Market Share by Country (2020-2031)
Figure 44. Turkey Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Acquired Immunodeficiency Syndrome Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Takeda Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2020-2025)
Figure 48. AstraZeneca Eli Lilly and Company Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2020-2025)
Figure 49. Merck KGaA Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2020-2025)
Figure 50. Sanofi Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2020-2025)
Figure 52. Amgen Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2020-2025)
Figure 53. Biogen Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2020-2025)
Figure 54. Novartis Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2020-2025)
Figure 55. Actelion Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2020-2025)
Figure 56. Daiichi Sankyo Company Revenue Growth Rate in Acquired Immunodeficiency Syndrome Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
